Product Images Buprenorphine Hydrochloride And Naloxone Hydrochloride Dihydrate

This is a medication with 216mg of buprenorphine HC, USP and 061mg of naloxone HCl dihydrate, USP, typically used sublingually. Each tablet is equivalent to 2mg of buprenorphine base and 0.5mg of naloxone base. The medication should be kept out of reach of children and stored between 20°1025°C (68°t0 77°F) at USP Controlled Room Temperature. The usual dosage should be followed as per the package insert for complete prescribing information. The medication should be dispensed with the attached medication guide by a pharmacist who distributed it via Hikma Pharmaceuticals USA Inc. In case of accidental consumption by children, emergency medical care may be needed.*

This is a description of Buprenorphine and Naloxone Sublingual Tablets, USP. Each tablet contains 8.64mg of buprenorphine HCl, equivalent to 8mg of buprenorphine base, and 2.44mg of naloxone HCI, equivalent to 7mg of naloxone base. The usual dosage is not given, and it is advised to check the package insert for complete prescribing information. The medication should be stored between 20°C and 25°C. The tablets come in a package of 30 and should be kept away from children. There is also a note for the pharmacist to dispense with the attached Medication Guide. The tablets are distributed by Hikma Pharmaceuticals US Inc in Berkeley Heights, NJ.*